Indivior has agreed to pay $385 million to settle a class action lawsuit from drug wholesalers who claim that the drugmaker illegally stifled competition in order to maintain a monopoly on the opioid addiction medication Suboxone, according to Reuters. The company has already paid more than $130 million in settlements with dozens of U.S. states and health plans who sued after Indivior reformulated Suboxone as a dissolvable oral film and extended its patent past its original 2009 expiration date.
Related Posts
Eggs get a better rep
Eating eggs was once thought to be as bad as smoking cigarettes. But a new study debunks that idea. A study published in the journal Heart, says eating a…
Rare varieties a feast for the apple lover
Two tips for apple adventurers: 1. Don’t judge an apple by its skin. Bright red means nothing, according to Rowan Jacobsen, author of Apples of Uncommon…
Get serious about screening for colorectal cancer
Here’s some good news: Deaths from colorectal cancer have been dropping since the 1980s. There’s no mystery as to why — more people are getting tested….